Pioneering the Future of Human Longevity

Celljevity is dedicated to reversing aging, not just treating it. The company integrates cellular rejuvenation technology and AI-powered health optimization.

"Advanced therapies shouldn't be reserved for billionaires. Our goal is to make cellular rejuvenation accessible to families, not just oligarchs."

Our Mission

Democratizing Longevity Science

From Lab Discovery to Global Access—The Celljevity Story

Humanitarian Commitment

Tiered pricing based on location to maintain profitability while expanding access.

Beyond Anti-Aging

Preventive healthcare reimagined. Delaying Alzheimer's onset by 5 years saves global economies billions.

Our Foundation

The principles that guide our mission to make longevity accessible to all

Vision • Mission • Promise

Vision

A world where aging is a choice, not an inevitability

Mission

To reverse biological aging through safe, proven cellular rejuvenation technology

Promise

Evidence-based treatments with uncompromising safety standards

Core Values

Scientific Integrity

Every claim backed by data

Safety

Zero compromise on safety protocols

Innovation

Continuously advancing the science

Accessibility

Working to democratize longevity

Transparency

Open about our methods and results

Join Our Mission

Whether you're a patient, healthcare provider, researcher, or investor, we invite you to be part of the longevity revolution.

Our Team

World-Class Leadership

Led by experienced executives and guided by distinguished advisors

Leadership Team

Diederik van der Reijt

Chief Executive Officer

Paris, France

Serial biotech entrepreneur and investor founded Celljevity (cellular rejuvenation) and co-founded NKore Biotherapeutics (immunotherapies). Leveraging his background in trading and venture capital, he aims to scale science-backed innovations and democratize access to breakthrough cellular therapies.

Dr. Henk Viëtor

Chief Medical Officer

Amsterdam, Netherlands

Co-founded and led more than 20 life sciences companies, including Drug Discovery Factory, Skyline Diagnostics, Julius Clinical, DC4U, MyLife Technologies, and Oncodrone. Physician, scientist, and serial biotech entrepreneur with expertise in clinical immunology, transfusion medicine, and genetics.

Dr. Heshan "Grasshopper" Illangkoon PhD

Chief Innovation Officer

Florida, USA

Biomedical engineer and translational scientist focused on turning frontier longevity and regenerative medicine research into deployable therapies. Leads Celljevity's innovation pipeline, bridging AI-driven discovery, clinical partners, and global research networks.

Dr. Digvijay Gahtory

Chief Business Officer

Amsterdam, Netherlands

Has over 8 years of experience in strategy consulting and entrepreneurship. Has raised more than €100 million in financing for life science companies. Founder and CEO of Bimini Biotech.

Karen Brink

Chief Growth Officer

Oxford, England

Focuses on growth strategies and thought leadership. Skilled and experienced investor who has founded several healthcare companies. Holds a Blockchain Strategy degree from Oxford.

Rhys Tombling

Finance Director

London, England

Has 10 years of experience in the private sector, specializing in financial control & operations for start-ups and scale-ups in FMCG and SaaS. Holds an ACA-ICAEW accountancy qualification and a BA in Accountancy and Finance from Newcastle University.

Daniel Erasmus

Chief Artificial Intelligence Architect

Brussels, Belgium

Medical & Scientific Board

Dr. Yi Eve Sun

Chief Science Officer

Shanghai, China

Professor, UCLA Department of Molecular & Medical Pharmacology. Pioneer in neural stem cell biology and leading expert in cellular reprogramming. Academic excellence with breakthrough discoveries in JAK-STAT pathways and successful translation from bench to bedside.

Dr. Henry Delmar

Founder, Clinic Del Mar

Nice, France

Member of the European Board of Plastic Surgeons (EBOPRAS), specializes in Plastic, Reconstructive, and Aesthetic Surgery. President of the French Society of Aesthetic Plastic Surgery (SOFCEP) and member of IPRAS and ESPRAS.

Dr. Adeel Khan

Board-Certified Physician

Dubai, UAE

Board-certified physician and Co-founder of Minicircle, specializing in stem cell therapy and gene therapy applications. University of Ottawa medical graduate with clinical expertise in regenerative treatments. Through Eterna Health, operates international clinics focusing on cutting-edge longevity interventions.

Dr. Christopher Juel-Jensen

Chief Integration Officer

London, England

Surgeon, investment banker, and leader in longevity and regenerative medicine. Combines finance and medicine, previously working at J.P. Morgan, Goldman Sachs, Deutsche Bank, and Swiss Bank Corp., now developing healthcare and wellness platforms worldwide.

Dr. Pierre Maldiney

Cardiologist & Anti-Aging Physician

Paris, France

Cardiologist, morphologist, and anti-aging physician with training in nutritional and functional medicine with Professor Vincent Castronovo. President of AEM2F, the European Association of Mitronutrition and Functional Medicine.

Dr. Lin Quan

Clinical Director, UCLA

Los Angeles, USA

Clinical Director for preclinical research, focusing on Auto-rFib therapy research with expertise in cell culture and animal experiments. Leads preclinical investigations for neurodegenerative disease applications.

Doris Rathgeber

Medical Director, Body & Soul

Shanghai, China

Founder and Medical Director of Body & Soul in Shanghai. With over 20 years' experience in Traditional Chinese and Western Medicine, specializes in women's health, fertility, and pediatrics, delivering care in four languages.

Dr. Murat Bozkurt

Medical Advisor

Ankara, Turkey

Advisory Board

Paul Spiegel

Strategic Advisor

Tokyo, Japan

International business development executive with extensive experience in Asia-Pacific markets and cross-border partnerships. Specializes in strategic planning and market expansion for biotechnology companies, with deep expertise in regulatory affairs and commercial strategy.

Neil Bush

Senior Advisor

Houston, USA

Global business leader with 40+ years experience specializing in cross-border investments in Asia and the Middle East. Founder of the George H. W. Bush Foundation for U.S.-China Relations. Chairs Points of Light and the Bush School Advisory Board.

Anne Popkin

Strategic Advisor

USA

Senior executive and strategic advisor with extensive experience in finance, biotechnology, and investor advocacy. Recognized for leadership roles at major asset management firms and commitment to advancing women's representation in finance. Active philanthropist supporting education, science, and ocean preservation.

Stephen Bradley

Non-Executive Director

Hong Kong

Former British Consul-General to Hong Kong, graduated from Oxford in 1980 and studied at Fudan University. Leverages extensive diplomatic experience across Asia to advise on cross-border consultancy and strategic development. Serves on the boards of Cenovus Energy Inc., CK Asset Holdings, and Power Assets Holdings.

David Bizer

Investment Advisor

Singapore

Co-founder and Managing Partner of GCW Global Customised Wealth, specializing in private equity and family office investments. Previously held senior positions at Jasper Ridge Partners, Nomura, and Lehman Brothers. Has served as an economic advisor to two U.S. Presidents. Ph.D. in Economics from Stanford University.

Rachid Bouzouba

Co-Founder, MCM Partners

Hong Kong

Co-Founder and Chairman of MCM Partners, a Hong Kong-based merchant bank and corporate advisory firm. Accomplished finance executive with extensive leadership in global equities and derivatives, previously serving as Head of Global Equities at Nomura and Head of European Equities at Lehman Brothers.

Shirin Azad

Strategic Advisor

Europe

Medical Disclaimer: Celljevity's Prometheus technology is investigational and not FDA-approved. Research protocol options vary by jurisdiction. Individual results may vary. Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent disease. Consult your healthcare provider.